$10,000 of GINKGO BIOWORKS lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the Farm Bill; Issues related to biosecurity and biosurveillance, including High Path Avian Influenza; Issues related to biotechnology."
You can find more data on corporate lobbying on Quiver Quantitative.
DNA Insider Trading Activity
DNA insiders have traded $DNA stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $DNA stock by insiders over the last 6 months:
- MARK E. DMYTRUK (See remarks) has made 0 purchases and 5 sales selling 4,125 shares for an estimated $38,023.
- STEVEN P. COEN (See remarks) has made 0 purchases and 5 sales selling 2,429 shares for an estimated $21,667.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DNA Hedge Fund Activity
We have seen 1 institutional investors add shares of DNA stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPL WEALTH MANAGEMENT, LLC added 10,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $57,000
- PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO removed 2,928 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $28,752
- HOEY INVESTMENTS, INC removed 1,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $9,820
- IFP ADVISORS, INC removed 575 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $5,646
- C M BIDWELL & ASSOCIATES LTD removed 5 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $49
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
